People | Critical Path Institute

Home>About>People

Board of Directors
Leadership Team
Liaison FDA Advisors

Board of Directors

Leadership Team

Full profile
Stephen P. Arneric, PhD
Executive Director, Coalition Against Major Diseases
Full profile
Lewis Barbieri, JD
Director, Contracts, Legal Services, and Compliance
Full profile
Steve Broadbent, MBA
Chief Operating Officer
Full profile
Martha A. Brumfield, PhD
President and CEO
Full profile
Stephen Joel Coons, PhD
Program Officer, Clinical Outcome Assessment Program; Executive Director, Patient-Reported Outcome Consortium
Full profile
Graham Higson, M.Sc.
Executive Director of European Office
Full profile
Lynn D. Hudson, PhD
Chief Science Officer; Executive Director, Multiple Sclerosis Outcome Assessments Consortium; Executive Director, International Neonatal Consortium
Full profile
Jane Larkindale, D.Phil.
Executive Director, Duchenne Regulatory Sciences Consortium
Full profile
Rick Liwski
Chief Technology Officer and Director, Data Collaboration Center
Full profile
Ariana P. Mullin, PhD
Executive Director, Huntington's Disease Regulatory Science Consortium
Full profile
Inish O’Doherty, PhD
Executive Director, Transplant Therapeutics Consortium; Executive Director, Type 1 Diabetes Consortium
Full profile
Ann Robbins, PhD
Consultant, Regulatory Affairs
Full profile
Jennifer Robertson
Director, Human Resources
Full profile
Klaus Romero, MD, MS
Director of Clinical Pharmacology and Quantitative Medicine
Full profile
John-Michael Sauer, PhD
Program Officer, Biomarker Programs; Executive Director, Predictive Safety Testing Consortium
Full profile
Diane Stephenson, PhD
Executive Director, Critical Path for Parkinson's Consortium
Full profile
Elizabeth Gribble Walker, PhD
Consultant, Regulatory Affairs
Full profile
Raymond Woosley, MD, PhD
Founder and Former CEO, Current Senior Adviser

Liaison FDA Advisors

x